scispace - formally typeset
B

Brett E. Pickett

Researcher at Brigham Young University

Publications -  64
Citations -  2390

Brett E. Pickett is an academic researcher from Brigham Young University. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 17, co-authored 44 publications receiving 1775 citations. Previous affiliations of Brett E. Pickett include University of Alabama at Birmingham & J. Craig Venter Institute.

Papers
More filters
Journal ArticleDOI

ViPR: an open bioinformatics database and analysis resource for virology research

TL;DR: The Virus Pathogen Database and Analysis Resource (ViPR) is an integrated repository of data and analysis tools for multiple virus families supported by the National Institute of Allergy and Infectious Diseases (NIAID) Bioinformatics Resource Centers (BRC) program.
Journal ArticleDOI

A RESTful API for Access to Phylogenetic Tools via the CIPRES Science Gateway

TL;DR: The CIP RES RESTful application programmer interface (CRA), a web service that provides programmatic access to all resources and services currently offered by the CIPRES Science Gateway, is described.
Journal ArticleDOI

Influenza Research Database: An integrated bioinformatics resource for influenza virus research

TL;DR: The recent improvements in IRD are described including the use of cloud and high performance computing resources, analysis and visualization of user-provided sequence data with associated metadata, predictions of novel variant proteins, annotations of phenotype-associated sequence markers and their predicted phenotypic effects, hemagglutinin (HA) clade classifications.
Journal ArticleDOI

Virus pathogen database and analysis resource (ViPR): a comprehensive bioinformatics database and analysis resource for the coronavirus research community.

TL;DR: All of the data and integrated analysis and visualization tools in ViPR are made available without charge as a service to the Coronaviridae research community to facilitate the research and development of diagnostics, prophylactics, vaccines and therapeutics against these human pathogens.